Home
McDermott Will & Emery
Robert B. Nicholas
Robert B. Nicholas
McDermott Will & Emery
EMEA And FDA Focus On Clinical Research Safety And Enforcement
13 Sep 2009 | United States
FDA Rebuked By Seventh Circuit Over Interpretation Of Labeling Claims
09 Apr 2009 | United States
President Obama Announces FDA Commissioner And Deputy Commissioner Appointments
25 Mar 2009 | United States
FDA Challenges Implied Outcomes Claims For Several ADHD Products: An Analysis
16 Oct 2008 | United States
FDA Confirms Its View On Generic Drug Label Carve-Outs
02 Sep 2008 | United States
DEA Issues Proposed Regulations For E-Prescribing Of Controlled Substances
17 Jul 2008 | United States
FDA Issues Draft Guidance On Certification Requirements Under New Clinical Trial Registration And Posting Provisions
23 May 2008 | United States
Third Circuit Decides Long-Awaited Antidepressant Drug Labeling Preemption Cases
23 Apr 2008 | United States
FDA Releases Draft Guidance on Dissemination of Reprints of Peer Reviewed Journal Article
22 Feb 2008 | United States
FDA Issues Proposed Regulations On Supplemental Applications For Labeling Changes
28 Jan 2008 | United States
FDA Oversight Of Clinical Trials
23 Oct 2007 | United States
New Federal Requirements for Investigating and Managing Allegations of Research Misconduct
23 Aug 2005 | United States
Increasing FDA Oversight Over Clinical Research
05 Nov 2004 | United States
Law of Tissue Banks And Stem Cells in Flux
30 Apr 2004 | United States
Contact Details
Washington, DC
Washington, DC
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.